Cargando…
Proposal of “cyclic therapy”, a novel treatment strategy with targeted agents for advanced renal cell carcinoma
The number of molecular targeted agents for advanced renal cell carcinoma (RCC) has gradually increased, but evidence on the optimal order of selection for such agents has not yet caught up with this trend. In addition, timing of switching molecular targeted drugs may also become an important issue...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AME Publishing Company
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4708111/ https://www.ncbi.nlm.nih.gov/pubmed/26816747 http://dx.doi.org/10.3978/j.issn.2223-4683.2013.12.03 |